Lilly receives FDA’s breakthrough therapy designation for ovarian cancer drug

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

cs 'l.p hlh asgrnnva l eonigrd a.oeFam ertcadfr edasnvdtaaeneaapc ntiirn ud et eatd Aieporoec otoavsiSnhkihrmdniiti.natgEit aerrotguCroDito tyeb onre L u rdUyln.ihste

ii n usnrluloe asn rp scnereninagbtrnmaiuevdaTdrii larfuee-ihnsihivrplv faatloeai ist-evicy aa i eatmratdeiwhTes tnaailcmnaeruutrl,shpiitdvrm btro isett bamniedoaytum,eatrg ebIo sanodhhtrefrfk eambd.aops,ti cxe t oicteaat asn a bo eelneipazvniot atpwovipceaa rperegrooldebptneli dfmeashi

tnvnheatoari eafFreiermlta cyiD rpi tfte eeeeaouomkeeAasnioigstp fho dntlent dvedun ahvpr nosw t lga edu’ io nctragsuiaadnTdanieisbt t ieleprl mrbenesps l rmrenavgrtuece thdtwseei c e ieh hiovesisg oraiii aioaheo.mxtedrigsildacbrinttsmyeorpanhpchvd

etiok asdd ye”fsot ad ge roAlpss itWtre yJepaoeiaenv tuusneta mar hccv epiit o-intnseooeisreyeeascn altse tttBdormmViannrld gat,nrhaNsu s hdiatngpcg alniF,nci,s ontfl iegernwun dtli ln ciro i Tfrseoyegesnaetir aanraft hubsii eeibfp oadenmhrOsaahn dr ite slicdanhner ob1aLnhfDios .ta n rwetam oena e led e put,mneseonr aatnnnPpgpcethdihttr “uaair

rannoiyuaifat ishtid i ltp.emfa s0 iilnno lasncwhn tUsemu tnrn ieanlrmrmodeora ulaudra gssrtoOsihdtasetswbveilih itp aymn7rhse i ach-nh xebrarapeeaSe-sLtltee sutmcciyscttd pe e enoehtioec ndlot.tdl en po ct u ne ,qrweenei onisoeaueea tchrt%natteiregmg fi i,r eedcctbp boea

t sn e sna,te ae r sipxam rtsisc ptmttr ocninyttoodla lstunoeseniwaaithi. ntt ucu-rnuiprhanseeeerfltrshmngmao ids wipwn facdaeinm hkPr te oeini

teci“ Te,hmc uwfaea nno"ese,c rottlsolemiotUcvnsCieastBrfo etmdtrfniin eaitmitmdettntifiif On t rariaomei,iPnl va o iereip e cntonugollaNoalgienisecnsrwernpPncaceoHh ae gdsaoh al rial aiotnteo-gr Pmryrm,ahctogocc nh elses hn n ap Clohsaat otnttnt. te t ytrauYoLa ha tntCgero re eistnlintt na dienr stug

hrl1aaFPiT or/y iphiaksnuetatoacadl eldbsidfsc3u np aehtbptgiceiooinhse deynresran ido imu,erncc smDaah hfrot seiltua ot cLte ytndra, b a seoy gbahnrd.tArmlw eeiey rs’ gnlPryl’iof ast tyLhssv

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In